[Pubmed] Triple M Syndrome: Implications for Hematology-Oncology Advanced Practice Providers
Posté : 20 sept. 2023 12:00
Clin J Oncol Nurs. 2023 Sep 15;27(5):463-467. doi: 10.1188/23.CJON.463-467.
ABSTRACT
During the past decade, immune checkpoint inhibitors (ICIs) have revolutionized the landscape of cancer treatment. ICI-related side effects occur via direct overactivation of the immune system, and patients can experience sym.
PMID:37729456 | DOI:10.1188/23.CJON.463-467
Source: https://pubmed.ncbi.nlm.nih.gov/3772945 ... t6+86293ac